NDC codes

415010 NDC codes with hospital pricing data in the network.

• NDC 00904-5523-61 — Doxazosin 2 mg tabletsAI (484 hospitals, 32,533–33,136 samples)
• NDC 00942-0641-04 — Anticoagulant citrate dextrose solutionAI (529 hospitals, 32,115–33,132 samples)
• NDC 00378-9102-16 — Nitroglycerin 24-hour skin patch, 0.1 mg per hourAI (472 hospitals, 32,016–33,132 samples)
• NDC 00409-2308-02 — Midazolam injection, 10 mg per 2 mL vialAI (596 hospitals, 26,831–33,131 samples)
• NDC 00121-0893-15 — Chlorhexidine gluconate 0.12% mouth rinseAI (255 hospitals, 31,294–33,130 samples)
• NDC 55150-0425-01 — DILTIAZEM 5 MG/ML INTRAVENOUS SOLUTIONAI (151 hospitals, 29,755–33,130 samples)
• NDC 63323-0486-26 — Lidocaine 2% injection solutionAI (214 hospitals, 31,370–33,125 samples)
• NDC 00143-9332-01 — Bupivacaine 0.75% injection (preservative-free)AI (92 hospitals, 33,084–33,120 samples)
• NDC 64980-0513-05 — Timolol eye drops 0.25%AI (608 hospitals, 31,992–33,117 samples)
• NDC 63323-0488-37 — Lidocaine with epinephrine local anesthetic, 30 mL vialAI (545 hospitals, 29,931–33,117 samples)
• NDC 00143-9927-01 — ciprofloxacin 250 mg tabletAI (428 hospitals, 32,320–33,085 samples)
• NDC 00990-6143-22 — ACETIC ACID 0.25 % IRRIGATION SOLUTIONAI (130 hospitals, 32,030–33,083 samples)
• NDC 67457-0420-00 — Dexamethasone sodium phosphate injectionAI (269 hospitals, 26,562–33,078 samples)
• NDC 00407-1413-62 — Iohexol 300 contrast injectionAI (106 hospitals, 31,926–33,069 samples)
• NDC 00904-6704-61 — Pramipexole 0.25 mg tabletAI (389 hospitals, 32,406–33,054 samples)
• NDC 45963-0439-63 — Lactulose 10 g/15 mL oral solutionAI (185 hospitals, 31,875–33,045 samples)
• NDC 00904-6572-61 — Allopurinol 300 mg tabletsAI (566 hospitals, 32,357–33,041 samples)
• NDC 64980-0592-48 — Lactulose oral solution, 10 g per 15 mLAI (228 hospitals, 31,874–33,035 samples)
• NDC 00832-1213-01 — Warfarin sodium 2.5 mg tabletAI (376 hospitals, 32,430–33,033 samples)
• NDC 00409-4888-12 — Sodium chloride 0.9% injection, preservative-freeAI (201 hospitals, 32,282–33,011 samples)
• NDC 11980-0174-05 — Pred Mild 0.12% eye drop suspensionAI (593 hospitals, 31,799–32,987 samples)
• NDC 17478-0290-10 — Tobramycin eye dropsAI (276 hospitals, 32,059–32,977 samples)
• NDC 00338-5003-41 — Ceftriaxone 2 gram IV piggyback in dextroseAI (167 hospitals, 27,806–32,972 samples)
• NDC 00904-6478-61 — Donepezil 10 mg tabletAI (376 hospitals, 32,350–32,971 samples)
• NDC 51079-0991-20 — Tramadol 50 mg tabletsAI (407 hospitals, 32,131–32,932 samples)
• NDC 00406-0552-01 — oxyCODONE 5 mg tabletAI (461 hospitals, 32,210–32,912 samples)
• NDC 24208-0631-10 — Neomycin, polymyxin, and hydrocortisone ear dropsAI (798 hospitals, 31,890–32,898 samples)
• NDC 00071-1014-41 — Pregabalin 75 mg capsulesAI (499 hospitals, 32,228–32,894 samples)
• NDC 70069-0141-10 — Cisatracurium injection, 2 mg/mLAI (189 hospitals, 31,731–32,883 samples)
• NDC 24208-0555-55 — Bacitracin-polymyxin B antibiotic ointmentAI (1016 hospitals, 31,748–32,882 samples)
• NDC 00781-3150-95 — Cisatracurium injection, 2 mg/mLAI (210 hospitals, 31,748–32,864 samples)
• NDC 63739-0052-74 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (202 hospitals, 31,027–32,863 samples)
• NDC 00168-0004-80 — TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL CREAMAI (287 hospitals, 31,799–32,861 samples)
• NDC 00990-7926-09 — Dextrose 5% and half-strength saline IV solutionAI (288 hospitals, 32,357–32,861 samples)
• NDC 68462-0756-25 — Ketorolac tromethamine injection 30 mg/mLAI (231 hospitals, 32,119–32,857 samples)
• NDC 45802-0046-35 — Gentamicin 0.1% antibiotic ointment, 15 g tubeAI (654 hospitals, 31,762–32,851 samples)
• NDC 66312-0176-16 — Lidocaine with epinephrine numbing injection cartridgeAI (190 hospitals, 30,884–32,837 samples)
• NDC 42702-0103-05 — Phenylephrine 10% eye drops, 5 mL bottleAI (330 hospitals, 31,837–32,836 samples)
• NDC 00378-9071-16 — Rivastigmine 9.5 mg 24-hour transdermal patchAI (251 hospitals, 31,786–32,821 samples)
• NDC 00409-1761-10 — Marcaine spinal anesthetic injection (bupivacaine with dextrose)AI (366 hospitals, 26,526–32,808 samples)
• NDC 00904-6925-61 — Sertraline 50 mg tabletsAI (390 hospitals, 32,112–32,796 samples)
• NDC 00065-0359-05 — Cyclopentolate and phenylephrine eye dropsAI (343 hospitals, 31,640–32,738 samples)
• NDC 00121-0893-00 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (213 hospitals, 31,485–32,736 samples)
• NDC 00116-2001-15 — chlorhexidine gluconate 0.12 % mouthwashAI (243 hospitals, 31,654–32,734 samples)
• NDC 00093-0262-30 — FLUOCINONIDE 0.05 % TOPICAL CREAMAI (121 hospitals, 31,705–32,731 samples)
• NDC 55150-0342-25 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (88 hospitals, 31,381–32,722 samples)
• NDC 00487-9501-60 — Albuterol sulfate 2.5 mg nebulizer solutionAI (123 hospitals, 31,621–32,719 samples)
• NDC 00406-0552-62 — Oxycodone 5 mg tabletsAI (594 hospitals, 31,787–32,714 samples)
• NDC 51672-1263-01 — Nystatin and triamcinolone topical cream, 15 g tubeAI (570 hospitals, 31,632–32,712 samples)
• NDC 63323-0486-41 — Lidocaine 2% injection solutionAI (94 hospitals, 31,046–32,693 samples)